Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Blood Specimen Collection 19Surveys and Questionnaires 16Specimen Handling 15Radiotherapy 6Magnetic Resonance Spectroscopy 6trastuzumab deruxtecan 5Surgical Procedures, Operative 5Observation 5darolutamide 4Patient Reported Outcome Measures 4Magnetic Resonance Imaging 4Data Collection 4Cryosurgery 4Breath Tests 4ribociclib 3atezolizumab 3Watchful Waiting 3Ultrasonography 3Tomography, X-Ray Computed 3Standard of Care 3Radiation 3Letrozole 3Interviews as Topic 3Immune Checkpoint Inhibitors 3Hepatectomy 3Biopsy 3Bevacizumab 3palbociclib 2lorlatinib 2cemiplimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Tyrosine Kinase Inhibitors × 30 days × Clear all
NCT03958565 2026-06-03

Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations.

University of Colorado, Denver

Recruiting
100 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡